Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 135,438 shares at $39.30 ($5.3M) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($5.3M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.30 | 3,750 | $147K | 2.8% |
| 2 | $39.30 | 65,844 | $2.6M | 48.6% |
| 3 | $39.30 | 65,844 | $2.6M | 48.6% |
| Total | $39.30 avg | 135,438 | $5.3M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |